Bio Protocol vs HTX — how do they compare? Bio Protocol trades at Rp438.74 (market cap Rp982,11M, Rp157,98M 24h volume), while HTX trades at Rp0.0323 (market cap Rp28,89T, Rp375M 24h volume). The key difference: HTX is far larger — about 29416.3× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 898,2T / 1.000T HTX (90%) for HTX. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and HTX for 22 Days on average.
| BIO | HTX | |
|---|---|---|
Market Cap | Rp982,11M | Rp28,89T |
Volume (24h) | Rp157,98M | Rp375M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 898,2T / 1.000T HTX (90%) |
Typical Hold Time | 18 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
HTX token shows strong bullish momentum with current price at Rp0.0325 and market cap of Rp29.24T, supported by overwhelmingly positive moving average signals (13 buy vs 0 sell). The token has 90% of its maximum 1.000T supply in circulation with average hold time of 22 days. Technical indicators show ADX readings above 60 indicating strong trend strength, while RSI remains in neutral territory suggesting room for further upside.
Overall outlook is bullish with strong technical momentum, though limited fundamental updates and neutral oscillators suggest cautious optimism. Key opportunities include continued trend following, while risks involve high volatility and lack of recent ecosystem developments. Investors should monitor for protocol updates and exchange liquidity changes.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →HTX is the native token of HTX DAO, a decentralized organization that supports the decentralized economy. It facilitates transactions, offers fee discounts, and provides access to exclusive features and services. Token holders can also participate in governance through voting. HTX is designed to support contributors, community programs, partnerships, and platform growth while promoting liquidity through voluntary pledging. Operating without formal registration, HTX DAO prioritizes autonomy, transparency, and inclusivity, making the HTX token essential for innovation, governance, and ecosystem growth in the blockchain space.
Read more on HTX →